{"id":2160,"date":"2015-12-03T16:21:40","date_gmt":"2015-12-03T15:21:40","guid":{"rendered":"http:\/\/www.satt.fr\/?p=2160"},"modified":"2017-11-13T16:59:54","modified_gmt":"2017-11-13T15:59:54","slug":"libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/","title":{"rendered":"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat"},"content":{"rendered":"<p>Dans le cadre d\u2019un projet de d\u00e9veloppement de m\u00e9dicaments innovants pour le traitement des cancers, notamment du cancer du c\u00f4lon, m\u00e9lanome et cancer du pancr\u00e9as, l\u2019\u00e9quipe oncopharmacochimie et pharmacotoxicologie de l\u2019IBMM, la SATT AxLR et 4P Pharma ont conclu un accord de maturation en co-d\u00e9veloppement d\u2019un montant de 436\u00a0400 euros, avec une option sur licence. Le financement de ce programme, baptis\u00e9 \u00ab\u00a0Imiqualines\u00a0\u00bb, se partage entre la SATT AxLR et 4P Pharma.<\/p>\n<p><a href=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2015\/12\/Communiqu\u00e9-de-presse-4P-Pharma-SATT-AxLR-011215.pdf\" target=\"_blank\" rel=\"noopener\">&gt;&gt; Lire le communiqu\u00e9 de presse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans le cadre d\u2019un projet de d\u00e9veloppement de m\u00e9dicaments innovants pour le traitement des cancers, notamment du cancer du c\u00f4lon, m\u00e9lanome et cancer du pancr\u00e9as, l\u2019\u00e9quipe oncopharmacochimie et pharmacotoxicologie de l\u2019IBMM, la SATT AxLR et 4P Pharma ont conclu un accord de maturation en co-d\u00e9veloppement d\u2019un montant de 436\u00a0400 euros, avec une option sur licence. [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[535],"tags":[],"class_list":["post-2160","post","type-post","status-publish","format-standard","hentry","category-reussites"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redacteur SATT\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\"},\"author\":{\"name\":\"redacteur SATT\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\"},\"headline\":\"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat\",\"datePublished\":\"2015-12-03T15:21:40+00:00\",\"dateModified\":\"2017-11-13T15:59:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\"},\"wordCount\":100,\"articleSection\":[\"R\u00e9ussites\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\",\"url\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\",\"name\":\"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"datePublished\":\"2015-12-03T15:21:40+00:00\",\"dateModified\":\"2017-11-13T15:59:54+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\",\"name\":\"redacteur SATT\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/redacteur\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/","twitter_misc":{"Written by":"redacteur SATT"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/"},"author":{"name":"redacteur SATT","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c"},"headline":"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat","datePublished":"2015-12-03T15:21:40+00:00","dateModified":"2017-11-13T15:59:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/"},"wordCount":100,"articleSection":["R\u00e9ussites"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/","url":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/","name":"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"datePublished":"2015-12-03T15:21:40+00:00","dateModified":"2017-11-13T15:59:54+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/libmm-la-satt-axlr-et-4p-pharma-concluent-un-accord-de-partenariat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"L\u2019IBMM, la SATT AxLR et 4P Pharma concluent un accord de partenariat"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c","name":"redacteur SATT","url":"https:\/\/www.satt.fr\/en\/author\/redacteur\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/2160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=2160"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/2160\/revisions"}],"predecessor-version":[{"id":4728,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/2160\/revisions\/4728"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=2160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=2160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=2160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}